In focus · trending topic

acne vulgaris

47 stories · following the connections

Dermira to Present at Leerink Partners 6th Annual Global Healthcare Conference

By Nasdaq OMXFeb 8, 2017, 9:05 PM UTC

Final CIMZIA® (certolizumab pegol) Phase 3 Trial Meets Primary Efficacy Endpoint in Patients with Moderate-to-Severe Chronic Plaque Psoriasis

By Nasdaq OMXJan 19, 2017, 7:00 AM UTC

Dermira Provides Corporate Update

By Nasdaq OMXJan 6, 2017, 12:30 PM UTC

Lori Lyons-Williams Joins Dermira as Chief Commercial Officer

By Nasdaq OMXJan 5, 2017, 12:30 PM UTC

Dermira Elects Emmanuel Caeymaex to Board of Directors

By Nasdaq OMXJan 4, 2017, 9:06 PM UTC

Dermira Elects Emmanuel Caeymaex to Board of Directors

By Nasdaq OMXJan 4, 2017, 9:06 PM UTC

Dermira Initiates Phase 3 Clinical Program in Acne

By Nasdaq OMXJan 3, 2017, 12:30 PM UTC

Second CIMZIA® (certolizumab pegol) Phase 3 Trial Meets Co-primary Efficacy Endpoints in Patients with Moderate-to-Severe Chronic Plaque Psoriasis

By Nasdaq OMXDec 8, 2016, 7:00 AM UTC